Stronger Sell Today CANF ranks #3308 as SELL CANDIDATE. Weaker Sell
Today CANF ranks #3308 as SELL CANDIDATE.

CANF stock Can-Fite BioPharma Ltd

CANF stock
Can-Fite BioPharma Ltd

Tue 15'th Jan 2019

PERIOD 2018-10-16 - 2019-01-15
CHANGE 5.13%
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Buy
Request Prediction
0.00%
Predict

Can-Fite BioPharma Ltd Stock Analysis

Technical stock analysis for Tue 15'th Jan 2019

Sell candidate since 2019-01-03 Loss -3.15%
Shorts 3.14% ( 2018-12-31 )
Cash n/a
Loans n/a
Beta 1.46
ROA -35.45

Can-Fite BioPharma Ltd gained 5.13% in the last trading day, rising from $1.17 to $1.23 The price has fallen in 4 of the last 10 days and is down by -2.38% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 107 464 more shares were traded than the day before. In total, 152 268 shares bought and sold for approximately $187 290.00.

Close price at the end of the last trading day (Tuesday, 15th Jan 2019) of the CANF stock was $1.23. This is 5.13% more than the trading day before Monday, 14th Jan 2019.

During day the stock fluctuated 12.07% from a day low at $1.16 to a day high of $1.30.

30 day high of the CANF stock price was $1.40 and low was $1.00.
90 day high was $1.73 and low was $1.00.
52 week high for the Can-Fite BioPharma Ltd - $2.75 and low - $1.00.

Trend

Can-Fite BioPharma Ltd lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.89% during the next 3 months and, with 90% probability hold a price between $0.90 and $1.41 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Monday January 14, 2019, which indicates further gains until a new top pivot has been found. Can-Fite BioPharma Ltd has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Can-Fite BioPharma Ltd holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.25. On a fall, the stock will find some support from the short-term average at $1.21. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 67 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Can-Fite BioPharma Ltd finds support from accumulated volume at $1.21.

Support: $1.21 Price: $1.23 Resistance: $1.26

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 12.07%. For the last week, the stock has had a daily average volatility of 8.18%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today CANF ranks #3308 as SELL CANDIDATE. Weaker Sell
Today CANF ranks #3308 as SELL CANDIDATE.